GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrthoPediatrics Corp (NAS:KIDS) » Definitions » Cash Flow from Financing

OrthoPediatrics (OrthoPediatrics) Cash Flow from Financing : $6.8 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is OrthoPediatrics Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2024, OrthoPediatrics paid $0.0 Mil more to buy back shares than it received from issuing new shares. It spent $0.6 Mil paying down its debt. It paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.0 Mil from paying cash dividends to shareholders. It received $0.0 Mil on other financial activities. In all, OrthoPediatrics spent $0.6 Mil on financial activities for the three months ended in Mar. 2024.


OrthoPediatrics Cash Flow from Financing Historical Data

The historical data trend for OrthoPediatrics's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrthoPediatrics Cash Flow from Financing Chart

OrthoPediatrics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 91.02 46.73 0.01 135.97 7.30

OrthoPediatrics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -2.04 -0.02 9.39 -0.57

OrthoPediatrics Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

OrthoPediatrics's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

OrthoPediatrics's Cash from Financing for the quarter that ended in Mar. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OrthoPediatrics  (NAS:KIDS) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

OrthoPediatrics's issuance of stock for the three months ended in Mar. 2024 was $0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

OrthoPediatrics's repurchase of stock for the three months ended in Mar. 2024 was $0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

OrthoPediatrics's net issuance of debt for the three months ended in Mar. 2024 was $-0.6 Mil. OrthoPediatrics spent $0.6 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

OrthoPediatrics's net issuance of preferred for the three months ended in Mar. 2024 was $0.0 Mil. OrthoPediatrics paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

OrthoPediatrics's cash flow for dividends for the three months ended in Mar. 2024 was $0.0 Mil. OrthoPediatrics received $0.0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

OrthoPediatrics's other financing for the three months ended in Mar. 2024 was $0.0 Mil. OrthoPediatrics received $0.0 Mil on other financial activities.


OrthoPediatrics Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of OrthoPediatrics's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


OrthoPediatrics (OrthoPediatrics) Business Description

Traded in Other Exchanges
Address
2850 Frontier Drive, Warsaw, IN, USA, 46582
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
Executives
Terry D Schlotterback director 2850 FRONTIER DRIVE, WARSAW IN 46582
Fred Hite director, officer: Chief Financial Officer ORTHOPEDIATRICS, 2850 FRONTIER DR., WARSAW IN 46582
Dyer George Sinclair Mitchell director 55 ORCHARD ST., CAMBRIDGE MA 02140
Gregory A Odle officer: Executive Vice President 2850 FRONTIER DRIVE, WARSAW IN 46582
Joseph W Hauser officer: Sr VP & GM Trauma & Deformity 6428 RIDGELINE DR, HUDSON OH 44236
Jimmy Duane Mcdonald director 28662 N. 71ST STREET, SCOTTSDALE AZ 85226
David R Pelizzon director, 10 percent owner 2850 FRONTIER DR, WARSAW IN 46582
Squadron Capital Holdings Llc 10 percent owner 18 HARTFORD AVENUE, PO BOX 223, GRANBY CT 06053
Squadron Capital Llc 10 percent owner 2850 FRONTIER DR., WARSAW IN 46582
Harold Ruf director 2850 FRONTIER DR, WARSAW IN 46582
Jennifer N. Pritzker 10 percent owner C/O SQUADRON CAPITAL LLC, 104 S. MICHIGAN AVENUE, SUITE 500, CHICAGO IL 60603
Infante (reynolds) Marie C director 2850 FRONTIER DR, WARSAW IN 46582
Stephen F Burns director 2850 FRONTIER DRIVE, WARSAW IN 46582
Berry Bernie B Iii director 2850 FRONTIER DRIVE, WARSAW IN 46582
Mark C Throdahl director, officer: President and CEO ORTHOPEDIATRICS, 2850 FRONTER DR., WARSAW IN 46582